Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Of opioid peptides

McGough, JL, Introlni-Collison, IB and Castellano, C (1993) Involvement of opioid peptides in learning and memory. In Opioids II. Handbook of Experimental Pharmacology, Springer-Verlag, New York, pp. 429—448. [Pg.394]

Douglass, J.O. Civelli, 0. Birnberg, N. Comb, M. Uhler, M. Lissitzky, J.C. and Herbert, E. Regulation of expression of opioid peptide genes. Ann Neurol 16(Supp1) S22-S30, 1984. [Pg.47]

Since the discovery of the enkephalins in 1975 [11] a large number of endogenous opioid peptides have been detected in mammals, and at present three distinct families of opioid peptides are known (for a review, See Ref. 12). These are the enkephalins, the endorphins (a-, (J-, and y-), and the dynorphins and neoendorphins. The recently discovered endomor-phins [13] also may represent endogenous opioid peptides. Peptides with opioid activity have also been isolated from tryptic digests of milk casein... [Pg.155]

Hruby VJ, Agnes RS. Conformation-activity relationships of opioid peptides with selective activities at opioid receptors. Biopolymers (Peptide Sci) 1999 51 391-410. [Pg.175]

Wilkes BC, Schiller PW. Molecular dynamics simulations of opioid peptide analogs containing multiple conformational restrictions. Int J Peptide Protein Res 1992 40 249-254. [Pg.176]

Corbett AD, Gillan MGC, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE. Selectivities of opioid peptide analogues as agonists and antagonists at the 6-receptor. Br J Pharmacol 1984 83 271-279. [Pg.176]

Schiller PW, Weltrowska G, Schmidt R, Berezowska I, Nguyen TM-D, Lemieux C, Chung NN, Carpenter KA, Wilkes BC. Subtleties of structure-agonist versus antagonist relationships of opioid peptides and peptidomi-metics. J Receptor Signal Transduction Res 1999 19 573-588. [Pg.177]

Spanagel R., Herz A., Shippenberg T. The effects of opioid peptides on dopamine release in the nucleus accumbens an in vivo microdialysis study. J. Neurochem. 55 1734, 1990. [Pg.97]

Ni Q., Xu H., Partilla J., Costa B.D., Rice K., Rothman R. Selective labeling of K2 opioid receptors in rat brain by [125I]IOXY interactions of opioid peptides and other drugs with multiple K2a binding sites. Peptides. 14 1279, 1993. [Pg.103]

Gao, B., et al. Organic anion-transporting polypeptides mediate transport of opioid peptides across blood-brain barrier. J. Pharmacol. Exp. Ther. 2000, 294, 73-79. [Pg.280]

R. T., Acyloxyalkoxy-based cyclic prodrugs of opioid peptides evaluation of their chemical and enzymatic stability as well as their transport properties across Caco-2 cell mono-layers, Pharm. Res., 1999, 36, 24-29. [Pg.542]

Gudmundsson, O. S., Jois, S. D., Vander Velde, D. G., Siahaan, T. J., Wang, B., Borchardt, R. T., The effect of conformation on the membrane permeation of coumarinic acid- and phenylpropionic acid-based cyclic prodrugs of opioid peptides. J. Peptide Res. 1999, 53, 383-392. [Pg.542]

M. Chromosomal localization of opioid peptide and receptor genes in the mouse. Life Sci 1995 56 PL369-PL375. [Pg.482]

KM Sivanandaiah, VV Suresh Babu, C Renukeshwar. Fmoc-amino acid chlorides in solid phase synthesis of opioid peptides. Int J Pept Prot Res 39, 201, 1992. [Pg.215]

C. Ampasavate, G.A. Chandorkar, D.G. Vande Velde, J.F. Stobaugh, and K.L. Audus. Transport and metabolism of opioid peptides across BeWo cells, an in vitro model of the placental barrier. Int I Pharm. 233 85-98 (2002). [Pg.387]

O. S. Gudmundsson, K. Nimkar, S. Gangwar, T. Siahaan, R. T. Borchardt, Phenylpro-pionic Acid-Based Cyclic Prodrugs of Opioid Peptides That Exhibit Metabolic Stability to Peptidases and Excellent Cellular Permeation , Pharm. Res. 1999, 16, 16-23. [Pg.549]

Khachaturian H, Lewis ME, Alessi NE, Watson SJ. (1985). Time of origin of opioid peptide-containing neurons in the rat hypothalamus. J Comp Neurol. 236 538-46. [Pg.524]

Herman, B.H., Hammock, M.K., Arthur-Smith, A., Egan, J., Chatoor, I., Zelnik, N., Corradine, M., Appelgate, K., Boecks, R., and Sharp, S.D. (1986) Role of opioid peptides in autism effects of acute administration of naltrexone [abstract]. Soc Neurosci Abstr 12 320. [Pg.360]

Marchetti, B., Scifo, R., Batticane, N., and Scapagnini, U. (1990) Immunological significance of opioid peptide dysfunction in infantile autism. Brain Dysfunction 3 346-354. [Pg.361]

Structure-Activity Correlations of Opioid Peptide Hormones... [Pg.352]

Strong evidence indicates at least a familial pattern and perhaps a hereditary basis for some types of alcoholism ( 393). More recent data show that genotype accounts for approximately 33% of the overall variance in liability ( 394). In addition, specific neurocircuitry and neurochemical systems appear to be important in the etiology of alcoholism (395). Thus, positive reinforcement may be mediated by activation of g-aminobutyric acid (GABA) receptors, release of opioid peptides and dopamine, inhibition of glutamate receptors, and interactions with the 5-HT system. Furthermore, neurobehavioral effects of alcohol and their association with these various neurotransmitters serve as potential targets for novel drug therapies. [Pg.295]

Vaught, J.L., Rothman, R.B., Westfall, T.C. Mu and delta receptors their role in analgesia in the differential effects of opioid peptides on analgesia, Life Sci. 1982, 30, 1443-1455. [Pg.150]


See other pages where Of opioid peptides is mentioned: [Pg.446]    [Pg.446]    [Pg.450]    [Pg.450]    [Pg.451]    [Pg.300]    [Pg.370]    [Pg.386]    [Pg.46]    [Pg.156]    [Pg.117]    [Pg.543]    [Pg.337]    [Pg.333]    [Pg.134]    [Pg.122]    [Pg.681]    [Pg.154]    [Pg.156]    [Pg.573]   
See also in sourсe #XX -- [ Pg.27 , Pg.801 ]




SEARCH



Opioid peptides

© 2024 chempedia.info